Minimally Invasive Spleen Preserving Surgery to Treat Primary Splenic Hydatidosis: Short and Long Term Outcomes: A Cohort Study
Sponsor study identifier
observational
18
1 country
1
Study Start
January 1, 2015
Actual (reported)Primary Completion
June 30, 2021
Actual (reported)Study Completion
June 30, 2021
Actual (reported)This retrospective cohort study examines the effectiveness of minimally invasive spleen-preserving surgeries compared to total splenectomy for treating primary splenic hydatidosis in Jordan. Covering 18 patients from January 2015 to June 2021, the research highlights similar recurrence rates between both surgical approaches, emphasizing the benefits of spleen preservation in maintaining immune function and reducing septic risks, particularly in pediatric patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2015
Actual (reported)June 30, 2021
Actual (reported)June 30, 2021
Actual (reported)February 24, 2024
Actual (reported)March 4, 2024
Actual (reported)Incidence of Postoperative Short-Term Complications
The measure focuses on the incidence and nature of short-term complications following spleen-preserving surgeries compared to total splenectomy. Short-term complications may include infection, bleeding, or any other immediate post-surgical issues that impact recovery.
Up to 1 month post-operation
Incidence of Postoperative Long-Term Complications
This measure assesses the long-term complications associated with spleen-preserving surgeries versus total splenectomy. Specifically, it examines the recurrence of hydatid cysts as a significant long-term complication.
Up to 2 years post-operation
Minimally Invasive Surgery : Laparoscopic partial splenectomy, cystectomy, and cyst deroofing.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
This retrospective study involved patients diagnosed with primary splenic hydatid cysts, from January 2015 to June 2021. The study included medical records of 18 patients aged 14 years or older, diagnosed exclusively with primary, non-recurrent splenic hydatid cysts. Exclusion criteria encompassed individuals under 14 years, patients in late pregnancy, those with recurrent cysts, extra-splenic involvement, or less than two years of postoperative follow-up.
Anas Aljaiuossi
Irbid, 22110, Jordan
18 participants (actual enrollment reported by the registry).
First Submitted
February 24, 2024
First Posted
March 4, 2024
Study Start
January 1, 2015
Actual (reported)Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder Cancer
Contact the study team to confirm eligibility.
Primary Completion
June 30, 2021
Actual (reported)Study Completion
June 30, 2021
Actual (reported)Last Updated
March 4, 2024
Record last verified: 2024-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: